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The central nervous system (CNS) accommodates a diverse myeloid immune cell 
compartment which maintains CNS homeostasis in the steady state while contributing 
to tissue injury during infectious, autoimmune and neurodegenerative disease 
conditions. Autophagy and autophagy proteins exert fundamental roles during myeloid 
cell-related immune functions. Many of these tasks do not necessarily involve the 
canonical formation of a double-membrane structure known as the autophagosome and 
reflect non-canonical functions of the autophagy machinery.  Here, we illustrate recent 
insights, concepts and outstanding questions on how autophagy pathways in myeloid 









Autophagy in the CNS: from neuronal to myeloid cells  
 
Autophagy is a homeostatic process that enables eukaryotic cells to deliver cytoplasmic 
constituents for lysosomal degradation, to recycle nutrients and to survive during 
starvation [1]. In addition to these primordial functions, autophagy and autophagy 
proteins are increasingly recognized for their essential roles in the development, 
organization and functions of the immune system ranging from cell-autonomous 
defence and cell survival to coordination of complex multicellular immune responses. 
Many immune-related functions of conserved autophagy proteins in myeloid cells 
occur independently of autophagosome formation and include pattern recognition 
receptor-mediated uptake and phagocytosis of extracellular material for cell-surface 
recycling or lysosomal degradation.  
 
Current knowledge on in vivo autophagy functions within the CNS largely stems from 
experiments targeting neuronal cells, in which absence of autophagy proteins results in 
the spontaneous development of early neurodegenerative disease phenotypes 
associated with an age-dependent accumulation of ubiquitin-positive neuronal 
inclusions and widespread death of neurons, in line with the classical housekeeping 
function of autophagy [2,3]. 
 
More recent studies demonstrated that genetic ablation of specific autophagy proteins 
in CNS-resident and -infiltrating myeloid cells in vivo can mitigate or exacerbate 
immune-mediated tissue injury and clinical disease development depending on the 
experimental condition studied. In contrast to conventional autophagy, CNS 
pathologies have so far predominantly been associated with non-canonical autophagy 
protein functions. Non-canonical pathways include LC3-associated phagocytosis 
(LAP) and LC3-associated endocytosis (LANDO) which require some, but not all 
components of the autophagy machinery and bridge receptor-mediated 
phagocytosis/endocytosis with autophagy. In our article, we will illustrate immune 
functions of autophagy proteins in myeloid cells, highlight recent data on autophagy-
related functions in CNS resident and infiltrating myeloid cells during neuro-
inflammatory and neurodegenerative disease conditions and discuss open questions in 
the field.   
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Autophagy proteins control myeloid cell-related immune functions  
 
The autophagy machinery supports primarily three aspects of myeloid cell 
immunobiology, thereby affecting the main components of the CNS immune system. 
These are clearance of pathogens in a cell intrinsic manner, regulating pro-
inflammatory cytokine production and antigen processing for adaptive immune system 
stimulation [4,5]. These functions are fulfilled by AuTophaGy (ATG) proteins [6,7] 
(Figure 1). The protein kinase complex of ULK1 (ATG1 in yeast) integrates metabolic 
signals and is accordingly inhibited my mammalian target of rapamycin (mTOR) and 
activated by the AMP activated protein kinase (AMPK). It in turn then activates the 
type III phosphatidylinositol 3 (PI3) kinase complex containing VPS34 and Beclin-1 
(ATG6 in yeast). This kinase complex modifies membranes from which 
autophagosomes emerge by phosphorylating PI to PI3P. This membrane mark serves 
as docking site for ATG proteins that covalently link the ubiquitin-like molecules 
LC3A, LC3B, LC3C, GABARAP, GABARAP-L1 and GABARAP-L2 (ATG8 in 
yeast) to phosphatidylethanolamine (PE) in the isolation membrane that will give rise 
to autophagosomes. These LC3 lipidation proteins contain the E1-like enzyme ATG7, 
the E2-like enzymes ATG3 and 10, and the E3-like complex of ATG5, 12 and 16L1. 
The LC3 family of proteins facilitates membrane elongation and fusion of the double-
membrane surrounded autophagosome, as well as autophagic substrate recruitment via 
autophagy receptors, like p62 and NDP52, that contain a LC3-interacting region (LIR) 
[8]. The LC3 proteins are recycled from the outer autophagosome membrane by the 
protease ATG4, but degraded with the inner autophagosome membrane and its cargo 
in lysosomes upon fusion with these hydrolytic organelles.  
 
ATG proteins regulate cell-intrinsic, innate and adaptive immunity. Along these lines, 
autophagy degrades cytosolic pathogens that have escaped endosomes. This was 
initially demonstrated for group A streptococci [9], but also much research has focused 
on Salmonella and Mycobacterium tuberculosis [10,11]. These bacterial pathogens and 
some non-enveloped viruses escape endosomes with membrane damage. These 
damaged endosomes are degraded via galectin-8 mediated recognition of cytosolic 
exposure of their luminal glycosylation, and then degraded with their pathogen cargo 
by NDP52 recruited autophagy [12]. Furthermore, cytosolic bacteria are ubiquitinated 
and then also degraded by autophagy, often in a p62 dependent fashion. Apart from its 
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anti-microbial role the autophagy machinery regulates the inflammasome machinery 
that elicits IL-1 and IL-18 maturation and release [4]. For example, ULK1 complex 
dependent autophagy in the lung restricts inflammasome dependent inflammation 
during influenza A virus infection [13]. Moreover, absence of ATGs in myeloid cells 
can result in hyperinflammatory states due to the lack of damaged mitochondria 
clearance by autophagy resulting in reactive oxygen species (ROS) and DNA mediated 
inflammasome activation [14,15]. During adaptive immunity, the autophagy machinery 
in myeloid cells can support CD4+ T cell responses by delivering substrates for antigen 
loading onto MHC class II molecules [16-18] and regulates CD8+ and NKT cell 
responses through recycling of MHC class I molecules from the cell surface [19,20]. 
 
The ingenious machinery to remodel membranes and recruit effector molecules via the 
LC3 membrane tag is not only used for autophagosome formation during conventional 
autophagy, but also non-canonical functions during endo- and exocytosis, including 
LC3-associated phagocytosis (LAP), LC3-associated endocytosis (LANDO) and 
extracellular vesicle release [21,22] which can contribute to immune responses 
independent of autophagosome formation. In fact, many immune-related functions of 
conserved autophagy proteins associated with immune responses within the CNS 
compartment reflect non-canonical functions of the autophagy machinery as outlined 
below [23,24]. 
 
Myeloid cell diversity in the CNS 
 
The CNS and its meningeal coverings accomodate a heterogeneous class of innate 
immune cells that contribute to the maintenance of tissue integrity and function during 
development and adulthood, that is only surpassed by the reactive cellular diversity 
during pathology [25,26]. At large, CNS-resident myeloid cell compartment  can be 
divided into parenchymal cells such as microglia and the non-parenchymal subsets 
including dendritic cells and macrophage populations lining the outer barriers of the 
CNS, all of which occupy uniquely assigned tasks within the continuous maintenance 
of tissue homeostasis and immune surveillance [27,28].  
 
Autophagy protein functions in microglia  
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Microglial cells are the resident immune cells of the CNS, comprising 10% of brain 
cells, and appear to be the only myeloid cell type within the healthy CNS parenchyma 
(with the exception of a few mast cells) [29]. Although they are considered CNS 
macrophages, studies employing single-cell transcriptomic profiling revealed that 
microglia are transcriptionally and epigenetically distinct from other tissue 
macrophages or bone marrow-derived macrophages [30] and are yolk sac-derived [31]. 
Microglia are long lived in situ and able to self-renew without significant replacement 
by peripheral hematopoietic cells from the blood circulation during the life of a mouse 
[32]. As the brain develops, microglia undergo significant transcriptional and physical 
changes. Early microglia express genes associated with cell proliferation, whereas early 
postnatal and adult microglia predominantly express genes associated with 
phagocytosis and immune surveillance [33]. Physiological functions of microglia 
include synaptic refinement by removing axons and synaptic terminals through a 
process termed pruning and secretion of neurotrophic factors for the support of neuronal 
cells [34]. Microglial cells contribute to myelinogenesis and oligodendrocyte 
progenitor maintenance in the early postnatal brain and mediate myelin degradation 
within the aging brain [35]. Thus, once thought to act simply in response to pathogens 
or other immune-related stimuli, microglia actively shape the circuitry of the brain and 
maintain CNS homeostasis.  
 
Activation of microglial cells, a process characterized by morphological changes and 
upregulation of a spectrum of immune molecules such as CD11c, MHC class II, CD14, 
CD86, and CD44 is a hallmark of almost all degenerative and chronic immune-
mediated neurological diseases and is also observed during ageing when microglia 
develop a proinflammatory phenotype [29,36]. Comprehensive single-cell RNA 
analysis of CNS immune cells in neurodegenerative conditions recently discovered 
disease-associated microglia (DAM), a subset of microglia showing a unique 
transcriptional and functional signature with downregulation of homeostatic and 
upregulation of genes involved in lysosomal and phagocytic pathways. Mechanisms 
that induce DAM and their function in CNS pathology are unclear [36]. Most studies 
in experimental models of CNS pathologies such as Alzheimer´s disease (AD), 
Parkinson´s disease (PD), and multiple sclerosis (MS) suggest that microglia activation 
promotes disease development and progression through dysfunctional phagocytic 
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activity and neuronal damage caused by the release of proinflammatory cytokines, 
reactive oxygen species and/or complement-activating proteins [32]. 
 
Accumulating evidence indicates that the autophagy machinery in microglia 
contributes to the emergence, acceleration or amelioration of CNS disease conditions. 
So far, two specific mechanisms appear to be predominantly relevant to CNS 
pathology: activation of the inflammasome (Box 2) leading to the consecutive release 
of proinflammatory mediators and autophagy protein-mediated endo-/phagocytosis. 
Reduced expression of the autophagy protein Beclin-1 in microglia derived from 
human post-mortem AD brains suggested that lidded autophagy activity underlies 
impaired phagocytic receptor recycling and phagocytosis of aberrant aggregates [37]. 
Additionally, microglia from mice with microglial deficiency in Beclin-1 show 
exuberant secretion/production of IL-1 and IL-18 due to reduced autophagy-
facilitated depletion of inflammasomes, thereby perpetuating degeneration-associated 
neuroinflammation in a transgenic mouse model for neurodegeneration that 
coexpresses KM670/671NL mutated amyloid precursor protein (APP) and L166P 
mutated presenilin 1 (PSEN1) under the control of a neuron-specific Thy1 promoter 
element (APPPSEN1 mice) [38]. Conversely, peroxisome proliferator activated 
receptor alpha (PPARA)-mediated induction of microglial autophagy has been 
associated with an ameliorated phenotype in the APPPSEN1 model [39]. It has been 
recently shown that disruption of non-canonical autophagy in microglia via targeted 
deletion of Rubicon and ATG5 in vivo leads to the increased deposition of toxic -
amyloid (A) and subsequent cognitive impairment in the 5xFAD AD mouse model, 
while microglia-specific ablation of the essential canonical autophagy protein FIP200 
had no impact. Interestingly, pharmacological inhibition of actin polymerization and 
phagocytosis in microglia abrogated the internalization of the prototypical LAP-
substrate zymosan but left the internalization of the endocytic substrate dextran or A 
unperturbed, supporting the notion that A is predominantly taken up via the endocytic 
pathway rather than phagocytosis [40]. This is further supported by the fact that LC3+ 
A-containing vesicles colocalized with clathrin and the endosomal marker Rab5 [40].  
In line with earlier work [41] the proposed underlying pathomechanism appeared to be 
rather a microglial deficiency in the autophagy-dependent recycling of putative A 
 8 
receptors (CD36, TREM2, TLR4) back to the cell surface rather than insufficient 
phagosome maturation and cargo destruction. However, the precise molecular 
underpinnings of autophagy protein-assisted receptor turnover and how the LC3 
lipidation machinery is recruited to these Rab5 positive endosomes remains to be 
clarified. This newly characterized process, termed LC3-associated endocytosis 
(LANDO) which occurs through direct recruitment of the LC3 lipidation machinery to 
recycling endosomes and facilitates their return to the cell surface [37,40] needs to be 
distinguished from the previously identified non-canonical LAP initiated by recptor-
mediated phagocytosis [40,42] (Figure 2).  
 
Aberrant aggregation of -synuclein and microglial activation are closely associated 
with the development of PD as well as other synucleinopathies and exogenous fibrillary 
-synuclein may induce autophagy in microglia [43]. A cargo-selective autophagy 
process in microglia designated synucleinphagy has recently been identified to promote 
neuroprotection by efficient clearance of neuron-derived -synuclein in a mouse model 
of PD. This process depends on the TLR4-MyD88-NF-B axis to upregulate the 
autophagy receptor p62, leads to the endo- and phagocytosis-independent ingestion of 
extracellular -synuclein and subsequent targeting into autophagosomes therefore 
rendering the process to be a distinct entity from LAP and aggrephagy [44]. Microglia-
specific deletion of ATG5 during development leads to a marked PD-like impairment 
of motor coordination in mice as young as 3 months old due to excessive 
inflammasome-mediated release if IL-1 and the subsequent increase of 
proinflammatory mediator macrophage migration inhibitory factor (MIF) [45]. In 
keeping with this, Han and colleagues reported restrained inflammasome activation and 
amelioration of neurodegeneration following small molecule-mediated induction of 
autophagy in mice with a PD-like phenotype [46]. 
 
A role for microglial autophagy in autoimmune CNS inflammatory diseases such as 
MS has not been firmely established so far. Upon activation, e.g. in response to an 
inflammatory milieu, microglia readily upregulate MHC class II molecules on their cell 
surface and autophagy could deliver substrates for MHC class II loading [16,17]. MHC 
class II-mediated antigen presentation by microglial cells appears, however, to be 
negligible for the induction of the classical T cell-driven inflammatory disease model, 
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experimental autoimmune encephalomyelitis (EAE) [47-49]. Complement-mediated 
functions such as the propagation of synaptic dysfunction, increasingly emerge as 
important mechanisms by which microglia participate in neuroinflammation [50]. In 
keeping with this, hippocampi from patients with MS depict increased expression of 
C1q and activated C3 in close spatial proximity to microglial protrusions [51]. 
Additionally, microglia are likely to calibrate CNS immune responses to various stimuli 
via secretion of soluble factors, which may lead to both mitigation or enhancement of 
inflammation. However, as to how autophagy-pathways contribute to or restrain these 
microgial responses in the context of both sterile and infectious neuroinflammatory 
disease conditions remains to be determined. 
 
Autophagy protein functions in non-parenchymal CNS-associated myeloid cells 
 
Bona fide dendritic cells (DCs) comprise a group of functionally and phenotypically 
distinct professional antigen-presenting cells that are derived from a common dendritic 
progenitor (CDP) and can be broadly classified into conventional DCs (cDCs) and 
plasmacytoid DCs (pDCs). Despite their distinct ontological segregation from other 
myeloid subsets, their unambiguous identification has been proven challenging due to 
widespread overlap of surface markers with non-DCs such as monocytes and their 
progeny, microglia and other macrophages, which has made it difficult to pry apart the 
differential contributions of these subsets especially in the context of disease [52,53]. 
In the steady state, CNS CD11c+MHC class II+ DCs are sparsely distributed mainly 
within the leptomeninges and the choroid plexus, strictly non-parenchymal and mainly 
include two subsets of cDCs, while the presence and function of pDCs under this 
condition is subject to controversy and awaits further analysis [25,29,47]. Both, DCs 
depicting a surface marker expression in accordance with a cDC2 phenotype (CD11b+), 
as well as DNGR-1/CLEC9A+CD11blo DCs, resembling cross-priming cDC1s, have 
been identified in the choroid plexus of the uninjured brain. The latter having been also 
detected in the meninges [54,55]. CNS cDCs are virtually absent in the perivascular 
space, but readily detectable in the leptomeninges as CD11b+CD172a+ cDC2s, whereas 
CD11bnegCD24+ cDC1s dominate in the choroid plexus and can be further discerned in 
two subpopulations of XCR1+ and XCR1neg cells. High-throughput scRNA-seq 
profiling confirmed the overall scarcity of DC subsets in the steady state CNS, their 
absence in the perivascular space, and the predominant presence of cDCs in the 
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leptomeninges and the choroid plexus but failed to detect any pDCs during homeostatic 
conditions in the CNS [25]. The apparent enrichment of cDCs in the leptomeninges and 
the choroid plexus under homeostatic conditions render these compartments as 
preferred entry sites for T cells to undergo DC-mediated interaction with their cognate 
antigen. Indeed, a role for DCs in CNS immunity is best established for T cell-mediated 
disease conditions.  
 
A prototypical tool to study T cell-mediated neuroinflammation in vivo is experimental 
autoimmune encephalomyelitis (EAE), which not only serves as the pre-clinical model 
for MS but also permits the investigation of T cell–APC interactions in general. Before 
myelin-specific T cells can breach the glia limitans and infiltrate the parenchyma, they 
require reactivation by CNS-associated MHC class II-expressing APCs which have 
sampled myelin protein from oligodendrocytes [56].  Of all potential APCs isolated 
from the steady state CNS, only cDCs are able to present myelin antigen, which was 
processed in vivo from the unperturbed brain [57,58] and recent studies employing 
conditional deletion of MHC class II molecules indicated that cDCs are required for 
reactivating encephalitogenic CD4+ T cells within the healthy CNS [25,47,58].  
 
Genetic ablation of ATG5 in cDCs abrogates myelin peptide presentation to CD4+ T 
cells following phagocytosis of oligodendroglial cells and completely blocks clinical 
EAE development induced by myelin-specific CD4+ T cells [59,60]. CD11c-Cre-driven 
deletion of ATG7 was additionally reported to ameliorate actively induced EAE [61]. 
Moreover, one study using LysM-Cre mediated deletion of ATG7 in myeloid cells 
including DCs, found a delayed onset of EAE and accumulation of TH17 cells in the 
lung during their migration to the CNS indicating that the lungs function as a central 
organ that licenses T cell migration into the CNS during the development of 
neuroinflammation [62]. However, the relative contribution of this phenotype that can 
be attributed to bona fide DCs remains to be clarified. Myelin antigen is not intrinsically 
expressed by DCs and, therefore, requires phagocytosis and processing in order to 
activate T cells. LAP does not require components of the ULK1 complex, but is often 
dependent of NADPH oxidase 2 (NOX2) [42,63] that is assembled at VPS34 
phosphorylated membrane patches. While part of the protective effect may be attributed 
to non-DC myeloid cells, genetic ablation of Cybb/NOX2, similar to ATG5, in cDCs is 
sufficient to restrain encephalitogenic T cell recruitment into the CNS and to ameliorate 
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These data indicate that steady state cDCs sample and process myelin antigen through 
LAP within the healthy CNS, supporting the reactivation of encephalitogenic CD4+ T 
cells and subsequent EAE development. However, the Beclin 1–binding protein 
RUBICON has been shown to be required for LAP function [42] and global 
RUBICON-deficient mice show no alteration in their development of active EAE in 
comparison to littermate controls [65]. Therefore, DC-specific knockouts of RUBICON 
are warranted to further elucidate the function of LAP during CNS autoimmunity. 
 
Non-conventional but LAP-independent immune functions of ATGs in DCs include the 
support of MHC class I expression and cytotoxic CD8+ T cell and NKT cell responses. 
CD8+ T cell and NKT cell responses towards infectious pathogens are compromised in 
the absence of ATGs [19,20,66], in part due to internalization of classical and non-
classical MHC class I molecules. It remains, however, to be addressed whether these 
functions affect DC-mediated immune responses within the CNS. 
 
In comparison to microglia and DCs, the ontogeny, and function of non-parenchymal 
brain macrophages (i.e., border-associated macrophages [BAMs]) during 
embryogenesis or adulthood is less well characterized [67]. There are at least three 
distinct non-parenchymal macrophage populations during homeostasis: leptomeningeal 
(mM), perivascular (pvM) and choroid plexus macrophages (cpM) [28,68]. All 
three subsets of CNS endogenous macrophages are transcriptionally highly related to 
microglia (as opposed to peripheral monocytes and macrophages) and mostly originate 
prenatally from Linnegc-Kit+ extraembryonic yolk sac-derived erythromyeloid 
precursors [68,69]. Tissue-resident macrophages occupy central roles during 
homeostasis and the differential functions of individual BAM subsets is likely to be 
reflected in their strategic anatomical location. While pvM are involved in the 
development and maintenance of the CNS vasculature (including maintenance of 
blood-brain barrier integrity) [70,71], clear aberrant protein deposits [27,72] and, 
together with mM help to protect the CNS from invading microorganisms [73,74], 
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cpM are situated at the interface of the CNS and the peripheral immune system and 
may occupy important functions during steady state immunosurveillance, antigen-
presentation and phagocytosis. Using EAE as a model for sterile neuroinflammation, a 
recent study documented a comprehensive transcriptional landscape across all BAM 
populations that elaborately reflects the dynamic signature changes in response to a 
specific pathological context [25]. Whether autophagy proteins regulate survival or 
function of non-parenchymal brain macrophages has not been adequately addressed so 





Evidence that autophagy proteins in CNS myeloid cells contribute to inflammatory, 
vascular and degenerative brain diseases is emerging [75,76]. While current data 
indicate that non-canonical features of the autophagy machinery primarily execute CNS 
myeloid cell-related immune functions, a role for canonical autophagy pathways cannot 
not be exluded based on the limited data available so far. The clinical outcome of 
genetic ablation of autophagy proteins depends on the major immune function executed 
by targeted CNS myeloid cells. Autophagy deficiency in microglial cells mainly affects 
their ability for receptor-mediated endocytosis/phagocytosis and innate cytokine 
production while autophagy protein deficiency in DCs limits their efficacy to process 
antigen for CD4+ T cell activation. Physiological functions of specialized macrophage 
populations at the CNS borders and how they contribute to brain pathologies are 
incompletely understood and the role of autophagy proteins in these cell subsets 
remains to be clarified. The identification of autophagy proteins as central determinants 
in many CNS disease models and even in human diseases represents new opportunities 
for therapeutic intervention. A more complete understanding how individual pathways 
contribute to CNS pathologies, however, appears to be mandatory in order to efficiently 
target autophagy pathways for therapeutic purposes (see outstanding questions). 
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Text box 1: The inflammasome 
 
Inflammasomes, as a part of the innate immune system, constitute a variety of cytosolic 
signaling platforms that upon sensing foreign- or host-derived stressors, initiate in a 
caspase-dependent manner the maturation and release of proinflammatory cytokines 
IL-1 and IL-18 as well as the initiation of gasdermin D-mediated pyroptosis [77-80]. 
These multiprotein ultrastructures regularly contain an upstream sensor molecule (such 
as NLRP [NLR family pyrin domain containing]1, NLRP3, NLRC [NLR family CARD 
domain containing]4, AIM [Absent in melanoma]2), the adaptor unit ASC (apoptosis-
associated speck-like protein containing a caspase recruitment domain or CARD) and 
pro-caspase 1. During canonical inflammasome activation, recognition of an adequate 
stimulus leads to assembly of cytosolic oligomers resulting in the proteolytic cleavage 
of zymogen pro-caspase 1 into its enzymatically active form [80,81], whereas non-
canonical inflammasomes rely on caspase 11 (mouse)/ 4 (human) [82]. The differential 
stimulus specificity of individual inflammasome entities is highly dependent on the 
respective sensor molecule. While NLRC4 recognizes bacterial flagellin [83], NLRP1 
is activated by anthrax lethal factor [84] and AIM2 by double stranded DNA [85]. 
Solely the NLRP3 inflammasome, to date the most fully characterized unit, has been 
reported to be responsive to a wide range of danger signals such as ATP, silica, alum, 
uric acid crystals and fibrillary proteins and peptides such as -amyloid [79-81]. 
 
As the most abundant tissue resident innate immune cell, microglia have been the focus 
of interest regarding CNS-inflammasome activity and the downstream effector 
molecules of microglial inflammasome activation, i.e. IL-1 and IL-18, have been 
shown to execute pivotal functions during CNS homeostasis and pathology [86-88]. 
Furthermore, inflammasome-mediated promotion of pyroptosis, a proinflammatory 
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form of regulated cell death, is increasingly being recognized for participating in the 
pathogenesis of a variety of CNS conditions [89].  
 
Autophagy pathways are implicated in the regulation of inflammasome function at 
various steps of their activity. At first autophagy had been identified primarily as a 
negative regulator of the inflammasome in that the process limits inflammasome 
activity by removing triggering agents, inflammasome constituents or downstream 
effector molecules [90-93]. However, several studies have additionally identified 
autophagy as an auxiliary mechanism for inflammasome activity [94,95]. Furthermore, 
various inflammasome constituents interact with autophagy machinery members such 












Figure 1: Autophagy, cell membrane dynamics. Autophagosomes emerge by 
isolation membrane elongation, forming for example at the endoplasmic reticulum. 
During autophagy induction ULK1 (1) phosphorylates VPS34 that then phosphorylates 
membranes for the recruitment of the LC3 or ATG8 (8) lipidation complex of Atg5, 12 
and 16L1. The ubiquitin-like molecule ATG12 is activated by ATG7 and conjugated 
by ATG10 to ATG5. The ATG5/12/16L1 complex then ligates LC3 to the isolation 
membrane for substrate recruitment via autophagy receptors, like p62. LC3 or ATG8 
is proteolytically processed by ATG4, activated by ATG7 and conjugated by ATG3. It 
is thought that LC3 influences vesicular trafficking. The majority of this lipidated LC3 
or ATG8 needs however to be removed prior to fusion with lysosomes and is recycled 
from the outer membrane by ATG4. Syntaxin 17 (STX17) is involved in this 
autolysosome generation which leads to the degradation and molecular building blocks’ 
recycling of the inner autophagosome membrane, its cargo, LC3 or ATG8 coupled to 
the inner membrane and any autophagy receptors attached to it.  
 
Figure 2. LAP and LANDO as non-canonical autophagy pathways in CNS myeloif 
cells. (A) LC3-associated endocytosis (LANDO) in micoglia, modified from [40]: 
Clearance of fibrillary aggregates via putative Aβ surface receptors (e.g. TREM2 and 
CD36) followed by the consecutive lysosomal degradation of endocytosed cargo and 
autophagy machinery-dependent recycling of receptors back to the surface.  (B) LC3-
associated phagocytosis (LAP) in CNS DCs: binding of a LAP-triggering cell surface 
receptor (such as TIM-4, TLR2, FcR and Dectin-1) initiates receptor-mediated 
phagocytosis. Activation of membrane-bound NOX2 and the consecutive production 
of superoxide leads to accumulation of LC3 to the cytosolic side of the LAPosome 
membrane. Fully assembled LAPosomes may either fuse with other endocytic vesicles 
or directly merge with lysosomes for subsequent MHC class II-mediated presentation 
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(Box 1). Which path T cells take for immune surveillance of the CNS or when they initiate an
autoimmune process remain under debate.
Intravital two-photon laser scanning microscopy approaches showed that pathogenic effector
T cells enter the CNS from leptomeningeal rather than CP vessels [53–55,57]. After diapedesis
of the vessels, T cells encounter myelin Ag presented by meningeal APCs, which in turn triggers
a local activation process ultimately leading to the formation of the autoimmune CNS lesion.
Also β-synuclein-reactive T cells that induce autoimmune lesions in the cortex were recently
found to use this leptomeningeal route [56]. The relevance of the leptomeningeal pathway in
the initiation of EAE was also supported by earlier studies by Ransohoff and colleagues [59]
and there is evidence that the meninges also represent a site of early inflammatory processes
in MS [60].
However, T cells might also use alternative routes (i.e., through the CP or parenchymal vessels). It has
been speculated that the molecular mechanisms for T cell extravasation are dependent on the nature
of both the lymphocyte and the site of entry [52]. For example, T helper type 1 (TH1) cells preferentially
cross the BBB in the spinal cord microvessels in a VLA-4-dependent manner [61–63], while CCR6+
TH17 cells use the CP associated blood–CP barrier (BCPB) as their preferential entry site and require
high-affinity leukocyte function-associated antigen (LFA)-1 for their extravasation [62,64].
CSF











Figure 2. Antigen (Ag)-Specific T Cell Trafficking within the Healthy Brain. Activated T cells can leave the leptomeningeal blood vessels to screen the subarachnoid
space (SAS) for their cognate Ag [e.g., myelin oligodendrocyte glycoprotein (MOG) from oligodendrocytes (ODCs)]. CNS Ag-ignorant T cells remain in this location, where
they might either undergo cell death or be released again to the periphery via the cerebrospinal fluid (CSF) flow. However, in the case of confirmatory cognate Ag presen-
tation by CNS-associated Ag-presenting cells [APCs; particularly conventional dendritic cells (cDC2s)], CNS-specific T cells become reactivated and are able to breach the
glia limitans of the blood–brain barrier (BBB) and infiltrate the CNS parenchyma.
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